Bard1 Life Sciences Ltd (BD1)
Market Closed
ASX ASX Primary 47.85M Market Cap
- P/E Ratio
0% Div Yield
228,599 Volume
- Eps
Want to track BD1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
BD1 closed Thursday higher, an increase of 0% from Wednesday's close, completing a monthly decrease of -4.23%. Over the past 12 months, BD1 stock lost -26.88%.
BD1 is not paying dividends to its shareholders.
The last earnings report, released on Oct 19, 2016, missed the consensus estimates by -0.01%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
Bard1 Life Sciences Ltd has completed 1 stock splits, with the recent split occurring on Dec 01, 2020.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on ASX (AUD).
Bard1 Life Sciences Ltd (BD1) FAQ
On which exchange is it traded?
Bard1 Life Sciences Ltd is listed on ASX.
What is its stock symbol?
The ticker symbol is BD1.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 47.85M.
Has Bard1 Life Sciences Ltd ever had a stock split?
Bard1 Life Sciences Ltd had 1 splits and the recent split was on Dec 01, 2020.
Bard1 Life Sciences Ltd Profile
| Biotechnology Industry | Healthcare Sector | - CEO | ASX Exchange | AU000000BD12 ISIN |
| Australia Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
Website: https://www.bard1.com
2025 © Marketlog. All Rights Reserved.
